Why Minerva Neurosciences Is Trading Higher By: Benzinga via Benzinga January 21, 2015 at 21:21 PM EST After the close, Minerva Neurosciences Inc (NASDAQ: NERV) reported positive Phase 1 data with MIN-202 for treatment of sleep ... Read More >> Related Stocks: Johnson & Johnson Minerva Neuroscie